Champlain Investment Partners, LLC Veracyte, Inc. Transaction History

Champlain Investment Partners, LLC

$15.8 Billion
Q2 2024

A detailed history of Champlain Investment Partners, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 3,167,670 shares of VCYT stock, worth $116 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

3,167,670

Previous 2,697,600 17.43%

Holding current value

$116 Million

Previous $59.8 Million 14.83%

% of portfolio

0.44%

Previous 0.35%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$18.86 - $23.55 $8.87 Million - $11.1 Million	470,070 Added 17.43%	3,167,670 $68.6 Million
Q1 2024 May 13, 2024	BUY	$21.0 - $29.1 $10.7 Million - $14.8 Million	509,340 Added 23.28%	2,697,600 $59.8 Million
Q4 2023 Feb 13, 2024	SELL	$19.72 - $28.68 $2.29 Million - $3.33 Million	-115,940 Reduced 5.03%	2,188,260 $60.2 Million
Q3 2023 Nov 13, 2023	BUY	$22.33 - $29.92 $8.53 Million - $11.4 Million	381,855 Added 19.86%	2,304,200 $51.5 Million
Q2 2023 Aug 11, 2023	BUY	$20.96 - $26.99 $75,770 - $97,568	3,615 Added 0.19%	1,922,345 $49 Million
Q1 2023 May 12, 2023	SELL	$20.58 - $27.89 $763,517 - $1.03 Million	-37,100 Reduced 1.9%	1,918,730 $42.8 Million
Q4 2022 Feb 13, 2023	SELL	$15.31 - $29.94 $1 Million - $1.96 Million	-65,485 Reduced 3.24%	1,955,830 $46.4 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $1.23 Million - $2.07 Million	74,020 Added 3.8%	2,021,315 $33.6 Million
Q2 2022 Aug 12, 2022	BUY	$15.45 - $29.52 $1.99 Million - $3.81 Million	128,990 Added 7.09%	1,947,295 $38.8 Million
Q1 2022 May 12, 2022	BUY	$21.94 - $42.51 $1.11 Million - $2.16 Million	50,805 Added 2.87%	1,818,305 $50.1 Million
Q4 2021 Feb 10, 2022	BUY	$36.09 - $53.79 $6.9 Million - $10.3 Million	191,215 Added 12.13%	1,767,500 $72.8 Million
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $738,224 - $1.1 Million	20,725 Added 1.33%	1,576,285 $73.2 Million
Q2 2021 Aug 12, 2021	BUY	$32.94 - $56.62 $33 Million - $56.7 Million	1,001,895 Added 180.96%	1,555,560 $62.2 Million
Q1 2021 May 13, 2021	BUY	$44.47 - $81.38 $24.6 Million - $45.1 Million	553,665 New	553,665 $29.8 Million

Others Institutions Holding VCYT

# of Institutions

267

Shares Held

79.5M

Call Options Held

42.3K

Put Options Held

18.2K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.62B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Champlain Investment Partners, LLC with notifications on news.

Account

Champlain Investment Partners, LLC Veracyte, Inc. Transaction History